GET73 modulates rat hippocampal glutamate transmission: evidence for a functional interaction with mGluR_5

[1]  P Jeffrey Conn,et al.  Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity , 2010, Molecular Pharmacology.

[2]  K. Gregory,et al.  Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology , 2010, ACS chemical neuroscience.

[3]  P. Popik,et al.  Memantine reduces consumption of highly palatable food in a rat model of binge eating , 2010, Amino Acids.

[4]  A. Sharko,et al.  Metabotropic Glutamate Receptor 5 Activity in the Nucleus Accumbens Is Required for the Maintenance of Ethanol Self-Administration in a Rat Genetic Model of High Alcohol Intake , 2010, Biological Psychiatry.

[5]  F. Faggiano,et al.  Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. , 2010, The Cochrane database of systematic reviews.

[6]  M. Mamelak.  Narcolepsy and depression and the neurobiology of gammahydroxybutyrate , 2009, Progress in Neurobiology.

[7]  W. Koek,et al.  Behavioral Effects of γ-Hydroxybutyrate, Its Precursor γ-Butyrolactone, and GABAB Receptor Agonists: Time Course and Differential Antagonism by the GABAB Receptor Antagonist 3-Aminopropyl(diethoxymethyl)phosphinic Acid (CGP35348) , 2009, Journal of Pharmacology and Experimental Therapeutics.

[8]  R. Griffiths,et al.  Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. , 2009, Drug and alcohol dependence.

[9]  I. Maremmani,et al.  Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review , 2009, International journal of environmental research and public health.

[10]  A. Gasbarrini,et al.  The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data , 2009, Expert opinion on investigational drugs.

[11]  L. Vinadé,et al.  Effects of Chronic Restraint Stress and Estradiol Replacement on Glutamate Release and Uptake in the Spinal Cord from Ovariectomized Female Rats , 2009, Neurochemical Research.

[12]  W. Danysz,et al.  Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder , 2008, European Neuropsychopharmacology.

[13]  F. Carroll.  Antagonists at Metabotropic Glutamate Receptor Subtype 5 , 2008, Annals of the New York Academy of Sciences.

[14]  M. P. Castelli,et al.  Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse. , 2008, Mini reviews in medicinal chemistry.

[15]  R. Harris,et al.  Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. , 2008, The international journal of neuropsychopharmacology.

[16]  A. Loche,et al.  Sucrose intake: increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73. , 2008, Pharmacological research.

[17]  W. Koek,et al.  Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABAB receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists , 2008, Psychopharmacology.

[18]  W. Koek,et al.  Synergistic interactions between ‘club drugs’: gamma-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects , 2007, Behavioural pharmacology.

[19]  Q. Li,et al.  Effects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortex , 2007, Neuroscience.

[20]  A. Ottani,et al.  Preference for palatable food is reduced by the gamma-hydroxybutyrate analogue GET73, in rats. , 2007, Pharmacological research.

[21]  C. Hodge,et al.  mGlu5 receptors are involved in the discriminative stimulus effects of self-administered ethanol in rats. , 2006, European journal of pharmacology.

[22]  K. Drasbek,et al.  Gamma‐hydroxybutyrate – a drug of abuse , 2006, Acta neurologica Scandinavica.

[23]  W. Koek,et al.  Streptozotocin-induced diabetes differentially modifies haloperidol- and γ-hydroxybutyric acid (GHB)-induced catalepsy , 2005 .

[24]  D. Overstreet,et al.  The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats , 2005, Psychopharmacology.

[25]  W. Koek,et al.  Neuroleptic-like effects of γ-hydroxybutyrate: interactions with haloperidol and dizocilpine , 2004 .

[26]  L. Ferraro,et al.  Selective γ‐hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of γ‐hydroxybutyric acid , 2003 .

[27]  M. Croucher,et al.  Characterisation of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium‐dependent re‐uptake in rat cerebrocortical minislices , 2003, Journal of neurochemistry.

[28]  Fabrizio Gasparini,et al.  [3H]‐M‐MPEP, a Potent, Subtype‐Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5. , 2002 .

[29]  D. Aunis,et al.  Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. , 2002, Life sciences.

[30]  Fabrizio Gasparini,et al.  [(3)H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5. , 2002, Bioorganic & medicinal chemistry letters.

[31]  G. Tunnicliff,et al.  Gamma-Hydroxybutyrate (orphan medical). , 2002, Current opinion in investigational drugs.

[32]  G. Gessa,et al.  γ-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABAB receptors☆ , 2001 .

[33]  J. Kemp,et al.  Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Ferraro,et al.  γ‐Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study , 2001 .

[35]  M. Okun,et al.  GHB: an important pharmacologic and clinical update. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[36]  D. Savage,et al.  Characterization of electrically evoked [3H]-d-aspartate release from hippocampal slices , 2001, Neurochemistry International.

[37]  F. Gasparini,et al.  Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors. , 2001, Farmaco.

[38]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[39]  G. Gessa,et al.  Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. , 2000, Alcohol.

[40]  K. Fuxe,et al.  Neurotensin increases endogenous glutamate release in rat cortical slices. , 2000, Life sciences.

[41]  K. Fuxe,et al.  The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate–GABA Interaction via the Pallidal–Subthalamic Nucleus Loop , 1998, The Journal of Neuroscience.

[42]  M. Maitre.  THE γ-HYDROXYBUTYRATE SIGNALLING SYSTEM IN BRAIN: ORGANIZATION AND FUNCTIONAL IMPLICATIONS , 1997, Progress in Neurobiology.

[43]  C. Tanaka,et al.  NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus , 1996, Brain Research.

[44]  O. Snead,et al.  Thalamic NMDA receptors in the γ-hydroxybutyrate model of absence seizures: A cerebral microinjection study in rats , 1995, Neuropharmacology.

[45]  M. Maitre,et al.  Selective distribution pattern of γ-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography , 1992, Brain Research.

[46]  C. Cotman,et al.  Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. , 1991, Journal of medicinal chemistry.

[47]  C. Wermuth,et al.  High affinity binding site for γ-hydroxybutyric acid in rat brain , 1982 .

[48]  W. Koek,et al.  Behavioral analyses of GHB: receptor mechanisms. , 2009, Pharmacology & therapeutics.

[49]  M. Olive.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction. , 2009, Current drug abuse reviews.

[50]  J. Black,et al.  γ-Hydroxybutyrate/Sodium Oxybate , 2006 .

[51]  W. Koek,et al.  Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine. , 2004, European journal of pharmacology.

[52]  G. Gessa,et al.  gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors. , 2001, European journal of pharmacology.

[53]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[54]  M. Maitre.  The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. , 1997, Progress in neurobiology.

[55]  S. G. Howard,et al.  Does gamma-hydroxybutyrate inhibit or stimulate central DA release? , 1996, The International journal of neuroscience.

[56]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .